|
AP3M2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.410400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.530020E-01 |
| Normal-vs-Stage2 |
9.914800E-01 |
| Normal-vs-Stage3 |
4.287600E-01 |
| Normal-vs-Stage4 |
7.156800E-01 |
| Stage1-vs-Stage2 |
4.758800E-01 |
| Stage1-vs-Stage3 |
7.363000E-01 |
| Stage1-vs-Stage4 |
8.455200E-01 |
| Stage2-vs-Stage3 |
6.182400E-01 |
| Stage2-vs-Stage4 |
7.675400E-01 |
| Stage3-vs-Stage4 |
9.696000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.330200E-01 |
| Normal-vs-AfricanAmerican |
7.215200E-01 |
| Normal-vs-Asian |
2.538600E-01 |
| Caucasian-vs-AfricanAmerican |
5.742800E-01 |
| Caucasian-vs-Asian |
7.810000E-01 |
| AfricanAmerican-vs-Asian |
5.974200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.772400E-02 |
| Normal-vs-Female |
3.138600E-01 |
| Male-vs-Female |
1.066040E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.433800E-01 |
| Normal-vs-Extreme_Weight |
2.834300E-02 |
| Normal-vs-Obese |
6.805600E-01 |
| Normal-vs-Extreme_Obese |
6.370300E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.628000E-01 |
| Normal_Weight-vs-Obese |
6.486400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.128200E-01 |
| Extreme_Weight-vs-Obese |
1.424040E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.200800E-01 |
| Obese-vs-Extreme_Obese |
1.707010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.472400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.133400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.954400E-02 |
| Normal-vs-Age(81-100Yrs) |
1.656190E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.770600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.372800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.498400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.945600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.892640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.106000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.620350E-01 |
| Normal-VS-Type2 PRCC |
2.392200E-01 |
| Normal-VS-KIRP CIMP |
6.754600E-01 |
| Normal-VS-Unclassified PRCC |
4.557000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.739600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.969200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.704400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.921600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.569200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.843000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.907820E-02 |
| Normal-vs-N1 |
9.448600E-01 |
| Normal-vs-N2 |
9.583400E-01 |
| N0-vs-N1 |
2.091200E-01 |
| N0-vs-N2 |
3.642600E-01 |
| N1-vs-N2 |
9.948600E-01 |
|
|
